FDA Approves First Use for an Anticancer Therapeutic Based on Tumor Biomarker, Not Tumor Origin
Tuesday marked a milestone for the oncology community: The U.S. Food and Drug Administration (FDA) announced its first approval...
Category: AACR
Tuesday marked a milestone for the oncology community: The U.S. Food and Drug Administration (FDA) announced its first approval...
At the end of last week, the U.S. Food and Drug Administration (FDA) approved expanding the use of pembrolizumab...
May is National Cancer Research Month, and for the past 10 years, leaders and members from the American Association...
In recent years, the American Association for Cancer Research (AACR) has expanded its efforts to catalyze advances in cancer...
A study published recently in the AACR’s journal Cancer Discovery addresses the burgeoning question of the utility of high-throughput...
This time last year there were no immune checkpoint inhibitors approved by the U.S. Food and Drug Administration (FDA)...
After being diagnosed with cancer, some patients consider getting a second opinion. This may involve a pathologist confirming a...
Last week, a flurry of U.S. Food and Drug Administration (FDA) oncology approvals concluded with the approval of the...
Earlier this week, the U.S. Food and Drug Administration (FDA) announced that it had approved a new immune checkpoint...
Members of the AACR Project GENIE consortium presented their first analyses of the data during the Pan-Cancer Genomic Analysis...